Coronavirus belongs to the family Coronaviridae, is one of the large family of viruses, which parasite on different animal species, including bats, camels, and cattle (Biscayart et al., 2020). A new strain named COVID-19 by the World Health Organization (WHO) on February 11, 2020 shares the same clade within the subgenus sarbecovirus of the subfamily Orthocoronavirinae (Zhu et al., 2020). COVID-19, which was formerly named 2019-nCoV (Chen, Liu, & Guo, 2020; Zhou et al., 2020) causes respiratory, digestive, hepatic, and central nervous systems diseases in humans, animals, birds, and rodents. This virus infects humans through various means and spread between humans to humans, like MERS-CoV, SARS-CoV (Sousou, 2015), and now with this new virus named (SARS-CoV-2) (Albarello et al., 2020). Due to the epidemic nature and high rate of deaths, it is essential to develop prevention and therapeutic approaches for the control of this virus. A team of Chinese scientists at the National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, China, has already started work on designing